Generate Biomedicines Inc (GENB)

$17.41 +0.91 (5.52%)
Market Cap 2.23B
Revenue (ttm) 31.89M
Net Income (ttm) -203.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -637.03%
Debt to Equity Ratio 0.00
Volume 833,400
Avg Vol 825,486
Day's Range N/A - N/A
Shares Out 128.19M
Stochastic %K 80%
Beta N/A
Analysts Strong Sell
Price Target $25.40

Company Profile

Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5...

Industry: Biotechnology
Sector: Healthcare
Phone: (888) 469-0055
Address:
101 South Street, Suite 900, Somerville, United States
DeeB6999
DeeB6999 Jul. 2 at 4:00 PM
$NVAX by the way has anyone seen the 5 minute 9EMA on $GENB?
0 · Reply
TheCatalystCalendar
TheCatalystCalendar Jun. 27 at 5:24 PM
NVDA owns a bunch of $GENB article here: https://apple.news/AlUe1YpErTr2KFN1WkE8-Aw 👀 🤔 Not sure I can buy it at the two year high, but I also look at that chart and I think it’s beat old resistance and I’m not likely to see a sub $14 or even $16 opportunity. If I do then my decisions already made, I’ll be a buyer. If I don’t there’s still a good chance I try to join before the 2nd round of FOMOers. Rather be late in the first round than early in the 2nd…
0 · Reply
Kicking_Bear
Kicking_Bear Jun. 27 at 3:23 PM
$NVDA Know that Nvidia -- through its venture capital arm NVentures -- now owns 833,325 shares of a small biotechnology company called Generate Biomedicines (NASDAQ: GENB). $GENB
0 · Reply
rumneychel
rumneychel Jun. 27 at 12:47 AM
$GENB if you know you know $SPY
1 · Reply
makesomemoneybro123
makesomemoneybro123 Jun. 23 at 11:07 AM
$MGRX $GENB $KIDZ $RTB you've been saying that for weeks haha! Mlec is juts a shit
0 · Reply
AlxQzz
AlxQzz Jun. 22 at 11:44 AM
$PATH $GENB $WOK $JOBY yea , eating 💩
0 · Reply
Crom5775
Crom5775 Jun. 14 at 11:44 AM
$GENB great daytrading/swing trading stock as it continues to bounce around inside of this box until it doesn’t anymore
0 · Reply
Tien_2Win
Tien_2Win Jun. 8 at 1:57 PM
$GENB move to $RXRX for potential squeeze again today.
0 · Reply
CaesarZane
CaesarZane Jun. 7 at 9:14 PM
$FPS $GENB $FNUC 📈📈📈 https://youtu.be/uk632v0svsY
0 · Reply
Tien_2Win
Tien_2Win Jun. 6 at 4:15 PM
$GENB 16$ next week very possibly; while $RXRX will trigger Short Squeeze potential 2X
0 · Reply
Latest News on GENB
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts

Jun 22, 2026, 8:00 AM EDT - 12 days ago

AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts

Generate Biomedicines Slides: Corporate presentation

Jun 9, 2026, 7:00 AM EDT - 25 days ago

Generate Biomedicines Slides: Corporate presentation

Generate Biomedicines Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 3:20 PM EDT - 26 days ago

Generate Biomedicines Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

May 28, 2026, 4:20 PM EDT - 5 weeks ago

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

Generate Biomedicines price target raised to $22 from $20 at Morgan Stanley

2026-05-14T16:37:25.000Z - 7 weeks ago

Generate Biomedicines price target raised to $22 from $20 at Morgan Stanley

Generate Biomedicines price target raised to $25 from $16 at H.C. Wainwright

2026-05-08T10:32:33.000Z - 2 months ago

Generate Biomedicines price target raised to $25 from $16 at H.C. Wainwright

Generate Biomedicines Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 2 months ago

Generate Biomedicines Quarterly report: Q1 2026

Generate Biomedicines Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 2 months ago

Generate Biomedicines Earnings release: Q1 2026

Generate Biomedicines reports Q1 revenue $7.22M, consensus $4.75M

2026-05-07T11:16:37.000Z - 2 months ago

Generate Biomedicines reports Q1 revenue $7.22M, consensus $4.75M

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

May 7, 2026, 6:16 AM EDT - 2 months ago

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

Generate Biomedicines initiated with a Buy at H.C. Wainwright

2026-04-13T10:18:45.000Z - 2 months ago

Generate Biomedicines initiated with a Buy at H.C. Wainwright

Generate Biomedicines Slides: Corporate presentation

Apr 8, 2026, 7:00 AM EDT - 3 months ago

Generate Biomedicines Slides: Corporate presentation

Generate Biomedicines initiated with an Overweight at Cantor Fitzgerald

2026-03-24T11:56:18.000Z - 3 months ago

Generate Biomedicines initiated with an Overweight at Cantor Fitzgerald

Generate Biomedicines initiated with an Overweight at Cantor Fitzgerald

2026-03-24T10:25:46.000Z - 3 months ago

Generate Biomedicines initiated with an Overweight at Cantor Fitzgerald

Generate Biomedicines initiated with a Buy at Guggenheim

2026-03-24T09:15:42.000Z - 3 months ago

Generate Biomedicines initiated with a Buy at Guggenheim

Generate Biomedicines initiated with an Overweight at Morgan Stanley

2026-03-24T09:10:12.000Z - 3 months ago

Generate Biomedicines initiated with an Overweight at Morgan Stanley

Generate Biomedicines initiated with an Overweight at Piper Sandler

2026-03-24T09:00:31.000Z - 3 months ago

Generate Biomedicines initiated with an Overweight at Piper Sandler

Generate Biomedicines initiated with a Buy at Goldman Sachs

2026-03-24T08:35:11.000Z - 3 months ago

Generate Biomedicines initiated with a Buy at Goldman Sachs

Generate Biomedicines Slides: Corporate presentation

Mar 6, 2026, 6:00 AM EST - 4 months ago

Generate Biomedicines Slides: Corporate presentation

Opening Day: Generate Biomedicines makes public debut

2026-03-02T16:30:40.000Z - 4 months ago

Opening Day: Generate Biomedicines makes public debut

AGMB BOBS EIKN FPS FVAV MANE OFRM

Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut

Feb 27, 2026, 12:57 PM EST - 4 months ago

Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut

Generate Biomedicines opens at $15.00, IPO priced at $16.00

2026-02-27T17:55:43.000Z - 4 months ago

Generate Biomedicines opens at $15.00, IPO priced at $16.00

Generate Biomedicines opens at $15.00, IPO priced at $16.00

2026-02-27T17:40:41.000Z - 4 months ago

Generate Biomedicines opens at $15.00, IPO priced at $16.00

Drug developer Generate Biomedicines raises $400 million in US IPO

Feb 26, 2026, 8:11 PM EST - 4 months ago

Drug developer Generate Biomedicines raises $400 million in US IPO

Generate Biomedicines 25M share IPO priced at $16.00

2026-02-27T01:05:16.000Z - 4 months ago

Generate Biomedicines 25M share IPO priced at $16.00

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

Feb 26, 2026, 7:58 PM EST - 4 months ago

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

Generate Biomedicines Registration statement: Registration Filing

Feb 23, 2026, 7:00 AM EST - 4 months ago

Generate Biomedicines Registration statement: Registration Filing

Generate Biomedicines aims to raise $425 million in US IPO

Feb 23, 2026, 6:45 AM EST - 4 months ago

Generate Biomedicines aims to raise $425 million in US IPO

Generate Biomedicines Registration statement: Registration Filing

Feb 13, 2026, 7:00 AM EST - 5 months ago

Generate Biomedicines Registration statement: Registration Filing

Generate Biomedicines, Clinical-Stage Generative Biology Company Designing AI-Engineered Protein Therapeutics, Files for Nasdaq IPO

Feb 4, 2026, 5:08 PM EST - 5 months ago

Generate Biomedicines, Clinical-Stage Generative Biology Company Designing AI-Engineered Protein Therapeutics, Files for Nasdaq IPO

Generate Biomedicines IPO Registration Document (S-1)

Feb 4, 2026, 5:02 PM EST - 5 months ago

Generate Biomedicines IPO Registration Document (S-1)

Asthma-focused AI biotech Generate Biomedicines files for a $100 million US IPO

Feb 4, 2026, 7:28 AM EST - 5 months ago

Asthma-focused AI biotech Generate Biomedicines files for a $100 million US IPO

DeeB6999
DeeB6999 Jul. 2 at 4:00 PM
$NVAX by the way has anyone seen the 5 minute 9EMA on $GENB?
0 · Reply
TheCatalystCalendar
TheCatalystCalendar Jun. 27 at 5:24 PM
NVDA owns a bunch of $GENB article here: https://apple.news/AlUe1YpErTr2KFN1WkE8-Aw 👀 🤔 Not sure I can buy it at the two year high, but I also look at that chart and I think it’s beat old resistance and I’m not likely to see a sub $14 or even $16 opportunity. If I do then my decisions already made, I’ll be a buyer. If I don’t there’s still a good chance I try to join before the 2nd round of FOMOers. Rather be late in the first round than early in the 2nd…
0 · Reply
Kicking_Bear
Kicking_Bear Jun. 27 at 3:23 PM
$NVDA Know that Nvidia -- through its venture capital arm NVentures -- now owns 833,325 shares of a small biotechnology company called Generate Biomedicines (NASDAQ: GENB). $GENB
0 · Reply
rumneychel
rumneychel Jun. 27 at 12:47 AM
$GENB if you know you know $SPY
1 · Reply
makesomemoneybro123
makesomemoneybro123 Jun. 23 at 11:07 AM
$MGRX $GENB $KIDZ $RTB you've been saying that for weeks haha! Mlec is juts a shit
0 · Reply
AlxQzz
AlxQzz Jun. 22 at 11:44 AM
$PATH $GENB $WOK $JOBY yea , eating 💩
0 · Reply
Crom5775
Crom5775 Jun. 14 at 11:44 AM
$GENB great daytrading/swing trading stock as it continues to bounce around inside of this box until it doesn’t anymore
0 · Reply
Tien_2Win
Tien_2Win Jun. 8 at 1:57 PM
$GENB move to $RXRX for potential squeeze again today.
0 · Reply
CaesarZane
CaesarZane Jun. 7 at 9:14 PM
$FPS $GENB $FNUC 📈📈📈 https://youtu.be/uk632v0svsY
0 · Reply
Tien_2Win
Tien_2Win Jun. 6 at 4:15 PM
$GENB 16$ next week very possibly; while $RXRX will trigger Short Squeeze potential 2X
0 · Reply
Scrufbag
Scrufbag Jun. 6 at 6:27 AM
$GENB $20 dollars next week.
0 · Reply
icanthinkofausername
icanthinkofausername Jun. 4 at 8:34 PM
$GENB loaded
0 · Reply
JohnStockDon
JohnStockDon Jun. 4 at 7:55 PM
$GENB 5x daily volume, probably nothing
0 · Reply
JohnStockDon
JohnStockDon Jun. 4 at 2:25 PM
$GENB Almost 2x average daily volume. Probably nothing. Jensen knows. $NVDA
1 · Reply
Olivia_Strickland
Olivia_Strickland Jun. 4 at 2:24 PM
$GENB up 15.8% but volume's actually below average, 0.96x. these breakouts without the crowd showing up make me cautious. no headline on my feed for it. holds 14 into the close or it fades back? on my swing list now: https://tapeboard.com/research/GENB?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=genb-bk-up-watch&utm_term=research
0 · Reply
JohnStockDon
JohnStockDon Jun. 4 at 2:13 PM
$GENB $50 stock, Jensen knows. $NVDA
0 · Reply
deadpoolish
deadpoolish Jun. 4 at 2:11 PM
$GENB Didn't expect the rebound this strong :) LFG!
1 · Reply
Tien_2Win
Tien_2Win Jun. 4 at 2:02 PM
$RXRX $GENB $TEM if volume 2-3X on $RXRX we will see short squeeze hard happen soon
0 · Reply
SicilianBull
SicilianBull Jun. 4 at 1:54 PM
$GENB 💰
0 · Reply
Tien_2Win
Tien_2Win Jun. 4 at 1:44 PM
$GENB and $RXRX both are AI Tech Health and in a good position advance forward. News and investors will join for the next big thing
0 · Reply
Washingtonstate
Washingtonstate Jun. 4 at 12:42 PM
$GENB $TELO $NU only up from here 😎
0 · Reply
JohnStockDon
JohnStockDon Jun. 3 at 6:29 PM
$GENB Has a drug in phase 3 trails for asthma that you take TWICE A YEAR. Another drug for COPD in phase 1 trials that you take TWICE A YEAR (hopefully phase 3 soon). If these work and go commercial this thing is a 10x. Jensen knows. $NVDA $NBIS
0 · Reply